Screening of Investigational Compounds to Treat, Modify or Prevent Epilepsy for the NINDS Epilepsy Therapy Screening Program (ETSP)
Overview
- Response deadline
- 12:00 PM UTC−05:00
- Posted
- December 13, 2021
- Notice type
- Solicitation
- Agency
- Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH
Notice details
- Office
- NATIONAL INSTITUTES OF HEALTH NIDA
- Last updated
- Sep 9, 2025
Identifiers
- Solicitation number
- 75N95022R00005
- Notice ID
- ea71aa8900d0449ea9a1e51abfcdab05
Description
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Documents
No documents available.
Lifecycle
75N95022R00005- Pre-Solicitation
- Solicitation
Award typically follows within 30–90 days after the response deadline. (estimate)
- Pre-SolicitationNov 3, 2021
Screening of Investigational Compounds to Treat, Modify or Prevent Epilepsy for the NINDS Epilepsy Therapy Screening Program (ETSP)
- 2×SolicitationNov 19, 2021
Screening of Investigational Compounds to Treat, Modify or Prevent Epilepsy for the NINDS Epilepsy Therapy Screening Program (ETSP)
- Pre-SolicitationNov 19, 2021
Screening of Investigational Compounds to Treat, Modify or Prevent Epilepsy for the NINDS Epilepsy Therapy Screening Program (ETSP)
- 2×SolicitationCurrentNov 23, 2021
Screening of Investigational Compounds to Treat, Modify or Prevent Epilepsy for the NINDS Epilepsy Therapy Screening Program (ETSP)
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Additional Details
Solicitation Number
75N95022R00005
Archive Date
Jan 5, 2022
Office Address
Bethesda, MD, 20892